SCHEMBL10055481

SCHEMBL10055481

CCCOc1c(I)c(OCCCS(=O)(=O)O)c(C(=O)OC)c(OCCCS(=O)(=O)O)c1-c1c(OCCCS(=O)(=O)O)c(I)c(OCCCS(=O)(=O)O)c(C(=O)OC)c1OCCC

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10078718 0.95 EGFR (0.31) MAPT
SCHEMBL10055405 0.94 RAB9A (0.32) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1
SCHEMBL725109 0.88 MAPT (0.33) MAPT
SCHEMBL10055299 0.84 SLC2A1 (0.35) RAB9AMAPTSMN1; SMN2L3MBTL1
SCHEMBL10078717 0.78 SLC2A1 (0.33) MAPTSMN1; SMN2
SCHEMBL10055482 0.75 CA1 (0.36)
SCHEMBL10055476 0.74 KMT2A (0.43) RAB9AMAPTL3MBTL1
SCHEMBL13373262 0.70 CA12 (0.33) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1
SCHEMBL11484722 0.69 CA1 (0.43) MAPTSMN1; SMN2L3MBTL1
SCHEMBL10078765 0.69 CA1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9702001-B2 Scaffold-based polymerase enzyme substrates PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2017-07-11 US disclosed
US-20150307933-A1 SCAFFOLD-BASED POLYMERASE ENZYME SUBSTRATES PACIFIC BIOSCIENCES CALIFORNIA (US) 2015-10-29 US disclosed
US-8906612-B2 Scaffold-based polymerase enzyme substrates PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2014-12-09 US disclosed
US-20120077189-A1 SCAFFOLD-BASED POLYMERASE ENZYME SUBSTRATES PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077189-A1 SCAFFOLD-BASED POLYMERASE ENZYME SUBSTRATES POLM, RNGTT, POLR1G RAB9A 3249/4885NPC1 3663/4885MAPT 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.